Drug reference
inhaled insulin
Antidiabetic agent
Antidiabetic agent
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Inhaled insulin is a formulation of insulin delivered via inhalation, designed for rapid onset and shorter duration of action compared to injected insulin analogues. It aims to control postprandial glucose levels.
Indications
Type 1 diabetes (in combination with long-acting insulin)Type 2 diabetes (in combination with long-acting insulin)
Pharmacokinetics
Onset
<0.5 h
Peak effect
1-2 h
Duration
3 h
Side effects
Common
CoughThroat irritation
Related guidelines
Fluid and electrolyte management in diabetes
RSSDI · Endocrinology · 2025
Diabetes management during Ramadan
ADA · Endocrinology · 2025
Glucose monitoring in diabetes
RSSDI · Endocrinology · 2024
Gestational diabetes mellitus
FOGSI · Obstetrics & Gynaecology · 2023
Type 2 diabetes in adults
RSSDI · Endocrinology · 2022
Other Unclassified drugs
Ask House about inhaled insulin
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team